Facebook Linkedin RSS Twitter Youtube
Home 2024

Sarepta Therapeutics

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial
Drug Discovery

Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial

Top 10 Best-Selling Cell and Gene Therapies
A-Lists

Top 10 Best-Selling Cell and Gene Therapies

StockWatch: Alto, Fractyl, FibroBiologics Join Parade of Public Biotechs
Cancer

StockWatch: Alto, Fractyl, FibroBiologics Join Parade of Public Biotechs

2023 Year in Review: Business Developments
Industry News

2023 Year in Review: Business Developments

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment
Artificial Intelligence

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment

Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets
Drug Discovery

Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets

FDA Lifts Clinical Hold on Pfizer DMD Gene Therapy Linked to Patient Death
Drug Discovery

FDA Lifts Clinical Hold on Pfizer DMD Gene Therapy Linked to Patient Death

Top 5 Reasons behind the Biopharma Bear Market
GEN Edge

Top 5 Reasons behind the Biopharma Bear Market

Ten Life Science Analysts to Watch in 2020
A-Lists

Ten Life Science Analysts to Watch in 2020

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.